The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008
Abstract
OBJECTIVE: To estimate the prevalence of gout and hyperuricemia based on the latest nationally representative sample of US men and women (National Health and Nutrition Examination Survey [NHANES] 2007-2008). METHODS: Using data from 5,707 participants in NHANES 2007-2008, we estimated the prevalence of gout and hyperuricemia. During home interviews for NHANES 2007-2008, all participants were asked about a history of health professional- or physician-diagnosed gout. Our primary definition of hyperuricemia was a serum urate level of >7.0 mg/dl for men and >5.7 mg/dl for women. We explored potential secular trends in these estimates and their possible explanations by comparing them with estimates based on 18,825 participants in NHANES-III (1988-1994). RESULTS: The prevalence of gout among US adults in 2007-2008 was 3.9% (8.3 million individuals). The prevalence among men was 5.9% (6.1 million), and the prevalence among women was 2.0% (2.2 million). The mean serum urate levels were 6.14 mg/dl among men and 4.87 mg/dl among women, corresponding to hyperuricemia prevalences of 21.2% and 21.6%, respectively. These estimates were higher than those in NHANES-III, with differences of 1.2% in the prevalence of gout (95% confidence interval [95% CI] 0.6, 1.9), 0.15 mg/dl in the serum urate level (95% CI 0.07, 0.24), and 3.2% in the prevalence of hyperuricemia (95% CI 1.2, 5.2). These differences were substantially attenuated after adjusting for body mass index and/or hypertension. CONCLUSION: These findings from nationally representative samples of US adults suggest that the prevalence of both gout and hyperuricemia remains substantial and may have increased over the past 2 decades, which is likely related to increasing frequencies of adiposity and hypertension.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lawrence, R. C., Felson, D. T., Helmick, C. G., Arnold, L. M., Choi, H., Deyo, R. A., Gabriel, S., Hirsch, R., Hochberg, M. C., Hunder, G. G., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23176 · Cited by 5,499
Self-citationHajjar, I. (2003) · JAMA · doi:10.1001/jama.290.2.199 · Cited by 2,409
Preliminary criteria for the classification of the acute arthritis of primary gout
Wallace, S. L., Robinson, H., Masi, A. T., Decker, J. L., Mccarty, D. J., & Yü, T. (1977) · Arthritis & Rheumatism · doi:10.1002/art.1780200320 · Cited by 1,432
Zhang, W., Doherty, M., Bardin, T., Pascual, E., Barskova, V, Conaghan, P., Gerster, J., Jacobs, J., Leeb, B., Lioté, F., et al. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.055269 · Cited by 1,407
Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout
Becker, M. A., Schumacher, H. R., Wortmann, R. L., MacDonald, P. A., Eustace, D., Palo, W. A., Streit, J., & Joseph-Ridge, N. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050373 · Cited by 1,357
Purine-Rich Foods, Dairy and Protein Intake, and the Risk of Gout in Men
Choi, H. K., Atkinson, K., Karlson, E. W., Willett, W., & Curhan, G. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035700 · Cited by 1,178
Self-citationAlcohol intake and risk of incident gout in men: a prospective study
Choi, H. K., Atkinson, K., Karlson, E. W., Willett, W., & Curhan, G. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16000-5 · Cited by 748
Self-citationIndependent Impact of Gout on Mortality and Risk for Coronary Heart Disease
Choi, H. K., & Curhan, G. (2007) · Circulation · doi:10.1161/circulationaha.107.703389 · Cited by 666
Self-citationChoi, H. K., Atkinson, K., Karlson, E. W., & Curhan, G. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.7.742 · Cited by 625
Self-citationPrevalence of the Metabolic Syndrome in Individuals with Hyperuricemia
Choi, H. K., & Ford, E. S. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.06.040 · Cited by 601
Self-citation
Cited by
2016 updated EULAR evidence-based recommendations for the management of gout
Richette, P., Doherty, M., Pascual, E., Barskova, V, Becce, F., Castañeda-Sanabria, J., Coyfish, M., Guillo, S., Jansen, T. L., Janssens, H., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209707 · Cited by 1,681
Khanna, D., Fitzgerald, J. D., Khanna, P. P., Bae, S., Singh, M. K., Neogi, T., Pillinger, M. H., Merill, J., Lee, S., Prakash, S., et al. (2012) · Arthritis Care & Research · doi:10.1002/acr.21772 · Cited by 1,536
Self-citationGlobal epidemiology of gout: prevalence, incidence, treatment patterns and risk factors
Dehlin, M., Jacobsson, L., & Roddy, E. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0441-1 · Cited by 1,370
Global epidemiology of gout: prevalence, incidence and risk factors
Kuo, C.-F., Grainge, M. J., Zhang, W., & Doherty, M. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.91 · Cited by 1,179
Dalbeth, N., Merriman, T. R., & Stamp, L. K. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00346-9 · Cited by 1,087
Chen‐Xu, M., Yokose, C., Rai, S. K., Pillinger, M. H., & Choi, H. K. (2019) · Arthritis & Rheumatology · doi:10.1002/art.40807 · Cited by 1,072
Self-citationNeogi, T., Jansen, T. L. T. A., Dalbeth, N., Fransen, J., Schumacher, H. R., Berendsen, D., Brown, M., Choi, H., Edwards, N. L., Janssens, H. J. E. M., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-208237 · Cited by 888
Self-citationGenome-wide association analyses identify 18 new loci associated with serum urate concentrations
Study, L. C., Köttgen, A., CARDIoGRAM Consortium, DIAGRAM Consortium, ICBP Consortium, MAGIC Consortium, Albrecht, E., Teumer, A., Vitart, V., Krumsiek, J., et al. (2013) · Nature Genetics · doi:10.1038/ng.2500 · Cited by 836
Self-citationKhanna, D., Khanna, P. P., Fitzgerald, J. D., Singh, M. K., Bae, S., Neogi, T., Pillinger, M. H., Merill, J., Lee, S., Prakash, S., et al. (2012) · Arthritis Care & Research · doi:10.1002/acr.21773 · Cited by 728
Self-citationDalbeth, N., Choi, H. K., Joosten, L. A. B., Khanna, P. P., Matsuo, H., Perez-Ruiz, F., & Stamp, L. K. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0115-y · Cited by 693
Self-citationNeogi, T., Jansen, T. L. T. A., Dalbeth, N., Fransen, J., Schumacher, H. R., Berendsen, D., Brown, M., Choi, H., Edwards, N. L., Janssens, H. J. E. M., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39254 · Cited by 669
Self-citationComorbidities of Gout and Hyperuricemia in the US General Population: NHANES 2007-2008
Zhu, Y., Pandya, B. J., & Choi, H. K. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.09.033 · Cited by 655
Self-citationHyperuricemia and its related diseases: mechanisms and advances in therapy
Du, L., Zong, Y., Li, H., Wang, Q., Xie, L., Yang, B., Pang, Y., Zhang, C., Zhong, Z., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01916-y · Cited by 631
Liu, R., Han, C., Wu, D., Xia, X., Gu, J., Guan, H., Shan, Z., & Teng, W. (2015) · BioMed Research International · doi:10.1155/2015/762820 · Cited by 630
The Molecular Physiology of Uric Acid Homeostasis
Mandal, A. K., & Mount, D. B. (2015) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021113-170343 · Cited by 550
Definition of hyperuricemia and gouty conditions
Bardin, T., & Richette, P. (2014) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000028 · Cited by 499
Uric acid and cardiovascular disease
Ndrepepa, G. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.05.046 · Cited by 498
Roddy, E., & Choi, H. K. (2014) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2014.01.001 · Cited by 477
Self-citationSerum uric acid and the risk of cardiovascular and renal disease
Borghi, C., Rosei, E. A., Bardin, T., Dawson, J., Dominiczak, A., Kielstein, J. T., Manolis, A. J., Perez-Ruiz, F., & Mancia, G. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000701 · Cited by 463
Gout epidemiology and comorbidities
Singh, J. A., & Gaffo, A. (2020) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2020.04.008 · Cited by 456
Uric acid as a danger signal in gout and its comorbidities
Rock, K. L., Kataoka, H., & Lai, J.-J. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.143 · Cited by 444
Krishnan, Y., & Grodzinsky, A. J. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.05.005 · Cited by 443
Richette, P., Doherty, M., Pascual, E., Barskova, V., Becce, F., Castaneda, J., Coyfish, M., Guillo, S., Jansen, T., Janssens, H., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215315 · Cited by 440
Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease
Borghi, C., Agabiti-Rosei, E., Johnson, R. J., Kielstein, J. T., Lurbe, E., Mancia, G., Redon, J., Stack, A. G., & Tsioufis, K. P. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.07.006 · Cited by 435
Global Biobank Meta-analysis Initiative: Powering genetic discovery across human disease
Zhou, W., Kanai, M., Wu, K.-H. H., Rasheed, H., Tsuo, K., Hirbo, J. B., Wang, Y., Bhattacharya, A., Zhao, H., Namba, S., et al. (2022) · Cell Genomics · doi:10.1016/j.xgen.2022.100192 · Cited by 432
Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options
Bardin, T., & Richette, P. (2017) · BMC Medicine · doi:10.1186/s12916-017-0890-9 · Cited by 385
β-hydroxybutyrate deactivates neutrophil NLRP3 inflammasome to relieve gout flares
Goldberg, E. L., Asher, J. L., Molony, R. D., Shaw, A. C., Zeiss, C. J., Wang, C., Morozova-Roche, L. A., Herzog, R. I., Iwasaki, A., & Dixit, V. D. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.004 · Cited by 370
Lv, Q., Meng, X.-F., He, F.-F., Chen, S., Su, H., Xiong, J., Gao, P., Tian, X.-J., Liu, J.-S., Zhu, Z.-H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056864 · Cited by 364
An update on the genetics of hyperuricaemia and gout
Major, T. J., Dalbeth, N., Stahl, E. A., & Merriman, T. R. (2018) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0004-x · Cited by 332
Physiology of Hyperuricemia and Urate-Lowering Treatments
Benn, C. L., Dua, P., Gurrell, R., Loudon, P., Pike, A., Storer, R. I., & Vangjeli, C. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00160 · Cited by 319
Asymptomatic hyperuricaemia: a silent activator of the innate immune system
Joosten, L. A. B., Crişan, T. O., Bjornstad, P., & Johnson, R. J. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0334-3 · Cited by 319
High uric acid directly inhibits insulin signalling and induces insulin resistance
Zhu, Y., Hu, Y., Huang, T., Zhang, Y., Li, Z., Luo, C., Luo, Y., Yuan, H., Hisatome, I., Yamamoto, T., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.04.080 · Cited by 305
Self-citationHyperuricemia-Related Diseases and Xanthine Oxidoreductase (XOR) Inhibitors: An Overview
Chen, C., Lü, J.-M., & Yao, Q. (2016) · Medical Science Monitor · doi:10.12659/msm.899852 · Cited by 302
Crișan, T. O., Cleophas, M. C. P., Oosting, M., Lemmers, H., Toenhake-Dijkstra, H., Netea, M. G., Jansen, T. L., & Joosten, L. A. B. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206564 · Cited by 284
Choi, H. K., Soriano, L. C., Zhang, Y., & Rodriguez, L. A. G. (2012) · BMJ · doi:10.1136/bmj.d8190 · Cited by 278
Self-citationDual-energy CT for the diagnosis of gout: an accuracy and diagnostic yield study
Bongartz, T., Glazebrook, K. N., Kavros, S. J., Murthy, N. S., Merry, S. P., Franz, W. B., Michet, C. J., Veetil, B. M. A., Davis, J. M., Mason, T. G., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-205095 · Cited by 276
Soltani, Z., Rasheed, K., Kapusta, D. R., & Reisin, E. (2013) · Current Hypertension Reports · doi:10.1007/s11906-013-0344-5 · Cited by 272
Trifirò, G., Morabito, P., Cavagna, L., Ferrajolo, C., Pecchioli, S., Simonetti, M., Bianchini, E., Medea, G., Cricelli, C., Caputi, A. P., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-201254 · Cited by 272
Gout: why is this curable disease so seldom cured?
Doherty, M., Jansen, T. L., Nuki, G., Pascual, E., Perez-Ruiz, F., Punzi, L., So, A. K., & Bardin, T. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201687 · Cited by 271
Dual-Energy CT for the Musculoskeletal System
Mallinson, P. I., Coupal, T. M., McLaughlin, P. D., Nicolaou, S., Munk, P. L., & Ouellette, H. A. (2016) · Radiology · doi:10.1148/radiol.2016151109 · Cited by 242
Fructose Intake, Serum Uric Acid, and Cardiometabolic Disorders: A Critical Review
Caliceti, C., Calabria, D., Roda, A., & Cicero, A. (2017) · Nutrients · doi:10.3390/nu9040395 · Cited by 236
Cleophas, M. C. P., Crişan, T. O., Lemmers, H., Toenhake-Dijkstra, H., Fossati, G., Jansen, T. L., Dinarello, C. A., Netea, M. G., & Joosten, L. A. B. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206258 · Cited by 139
Remembering the forgotten non-communicable diseases
Lopez, A. D., Williams, T. N., Levin, A., Tonelli, M., Singh, J. A., Burney, P. G., Rehm, J., Volkow, N. D., Koob, G., & Ferri, C. P. (2014) · BMC Medicine · doi:10.1186/s12916-014-0200-8 · Cited by 108
Ayoub-Charette, S., Liu, Q., Khan, T. A., Au-Yeung, F., Blanco Mejia, S., de Souza, R. J., Wolever, T. M., Leiter, L. A., Kendall, C., & Sievenpiper, J. L. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-024171 · Cited by 67
Factors modulating the inflammatory response in acute gouty arthritis
Cleophas, M. C., Crişan, T. O., & Joosten, L. A. B. (2017) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000366 · Cited by 62
Metadata
- Authors
- Zhu, Y., Pandya, B. J., & Choi, H. K.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2011-09-27
- Volume
- 63
- Issue
- 10
- Pages
- 3136-3141
- ISSN
- 0004-3591 (ISSN-L)
- OpenAlex
- W1964439201
- Cited by
- 1,785
- References
- 38
- FWCI
- 64.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.